UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $12.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $339.0K | 2.7% |
| Other Investing | $5.0K | 0.0% |
| Dividends Paid | $3.7M | 29.5% |
| Other Financing | $2.9M | 23.5% |
| Net Cash Flow | $5.5M | 44.3% |